284 related articles for article (PubMed ID: 8964239)
21. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and dosage regimens of anti-inflammatory drugs.
Lees P; May SA; White D
Ann Rech Vet; 1990; 21 Suppl 1():73S-78S. PubMed ID: 2080850
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacokinetics and tolerance of an orally administered combination preparation containing phenylbutazone and prednisolone in the dog].
Kietzmann M; Meyer-Lindenberg A; Engelke A; Nolte I
Dtsch Tierarztl Wochenschr; 1996 Jan; 103(1):14-6. PubMed ID: 8647008
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and tissue elimination of flunixin in veal calves.
Kissell LW; Brinson PD; Gehring R; Tell LA; Wetzlich SE; Baynes RE; Riviere JE; Smith GW
Am J Vet Res; 2016 Jun; 77(6):634-40. PubMed ID: 27227502
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling.
Landoni MF; Lees P
Equine Vet J; 1995 Jul; 27(4):247-56. PubMed ID: 8536660
[TBL] [Abstract][Full Text] [Related]
26. Experimental uses of flunixin meglumine and phenylbutazone in food-producing animals.
Kopcha M; Ahl AS
J Am Vet Med Assoc; 1989 Jan; 194(1):45-9. PubMed ID: 2644181
[TBL] [Abstract][Full Text] [Related]
27. [Animal experimental evidence of the long-lasting efficacy of etofenamate by prolongation of the half-life after intramuscular application].
Dell HD; Brons J; Fiedler J; Kamp R; Pelster B
Arzneimittelforschung; 1990 Mar; 40(3):300-5. PubMed ID: 2346540
[TBL] [Abstract][Full Text] [Related]
28. The pharmacokinetics of transdermal flunixin meglumine in Holstein calves.
Kleinhenz MD; Van Engen NK; Gorden PJ; KuKanich B; Rajewski SM; Walsh P; Coetzee JF
J Vet Pharmacol Ther; 2016 Dec; 39(6):612-615. PubMed ID: 27121728
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
Johnstone IB
Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
[TBL] [Abstract][Full Text] [Related]
30. Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations.
Day RO; Francis H; Vial J; Geisslinger G; Williams KM
J Rheumatol; 1995 Dec; 22(12):2295-303. PubMed ID: 8835565
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of flunixin in the cat: enterohepatic circulation and active transport mechanism in the liver.
Horii Y; Ikenaga M; Shimoda M; Kokue E
J Vet Pharmacol Ther; 2004 Apr; 27(2):65-9. PubMed ID: 15096102
[TBL] [Abstract][Full Text] [Related]
32. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses.
Reed SK; Messer NT; Tessman RK; Keegan KG
Am J Vet Res; 2006 Mar; 67(3):398-402. PubMed ID: 16506899
[TBL] [Abstract][Full Text] [Related]
33. Plasma, urine and tissue concentrations of Flunixin and Meloxicam in Pigs.
Nixon E; Mays TP; Routh PA; Yeatts JL; Fajt VR; Hairgrove T; Baynes RE
BMC Vet Res; 2020 Sep; 16(1):340. PubMed ID: 32938437
[TBL] [Abstract][Full Text] [Related]
34. Plasma and urine pharmacokinetics of intravenously administered flunixin in greyhound dogs.
Morris T; Paine SW; Zahra P; Li E; Colgan S; Karamatic S
J Vet Pharmacol Ther; 2019 Sep; 42(5):505-510. PubMed ID: 31090076
[TBL] [Abstract][Full Text] [Related]
35. Effect of probenecid on the pharmacokinetics of flunixin meglumine and phenylbutazone in healthy mares.
Zertuche JM; Brown MP; Gronwall R; Merritt K
Am J Vet Res; 1992 Mar; 53(3):372-4. PubMed ID: 1595963
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses.
Coakley M; Peck KE; Taylor TS; Matthews NS; Mealey KL
Am J Vet Res; 1999 Nov; 60(11):1441-4. PubMed ID: 10566824
[TBL] [Abstract][Full Text] [Related]
37. The Safety and Pharmacokinetics of Carprofen, Flunixin and Phenylbutazone in the Cape Vulture (Gyps coprotheres) following Oral Exposure.
Fourie T; Cromarty D; Duncan N; Wolter K; Naidoo V
PLoS One; 2015; 10(10):e0141419. PubMed ID: 26512724
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of the enzymes responsible for the metabolism of the non-steroidal anti-inflammatory drugs, flunixin meglumine and phenylbutazone, in horses.
Knych HK; Finno CJ; Baden R; Arthur RM; McKemie DS
J Vet Pharmacol Ther; 2021 Jan; 44(1):36-46. PubMed ID: 32757313
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics after intravenous administration of flunixin meglumine in budgerigars (Melopsittacus undulatus) and Patagonian conures (Cyanoliseus patagonus).
Musser JM; Heatley JJ; Phalen DN
J Am Vet Med Assoc; 2013 Jan; 242(2):205-8. PubMed ID: 23276097
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamics and pharmacokinetics of flunixin in the cat.
Lees P; Taylor PM
Br Vet J; 1991; 147(4):298-305. PubMed ID: 1913126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
